{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T23:56:14Z","timestamp":1772841374839,"version":"3.50.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1097\/md.0b013e3181dfca14","type":"journal-article","created":{"date-parts":[[2010,5,7]],"date-time":"2010-05-07T02:01:58Z","timestamp":1273197718000},"page":"176-182","source":"Crossref","is-referenced-by-count":59,"title":["Use of Thalidomide for Severe Recurrent Aphthous Stomatitis"],"prefix":"10.1097","volume":"89","author":[{"given":"Muriel","family":"Hello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Barbarot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Bastuji-Garin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Revuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Chosidow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20210226","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1477-7525-1-40","article-title":"Assessment of oral health related quality of life.","volume":"1","author":"Allen","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"R2-5-20210226","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1046\/j.1523-1747.2002.19502.x","article-title":"Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients.","volume":"119","author":"Bastuji-Garin","year":"2002","journal-title":"J Invest Dermatol"},{"key":"R3-5-20210226","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000246279","article-title":"Thalidomide and recurrent aphthous stomatitis: a follow-up study.","volume":"193","author":"Bonnetblanc","year":"1996","journal-title":"Dermatology"},{"key":"R4-5-20210226","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-0528.2007.00329.x","article-title":"Risk indicators for recurrent aphthous ulcers among adults in the US.","volume":"35","author":"Chattopadhyay","year":"2007","journal-title":"Community Dent Oral Epidemiol"},{"key":"R6-5-20210226","first-page":"171","article-title":"Thalidomide et thromboses.","volume":"127","author":"Flageul","year":"2000","journal-title":"Ann Dermatol Venereol"},{"key":"R7-5-20210226","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/ard.53.12.828","article-title":"Clinical experience with thalidomide in the management of severe oral and genital ulcerations in conditions such as Behcet's disease: use of neurophysiological studies to detect thalidomide neuropathy.","volume":"53","author":"Gardner-Medwin","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"R8-5-20210226","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0190-9622(85)70014-X","article-title":"Significant response of oral aphthosis to thalidomide treatment.","volume":"12","author":"Grinspan","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"R9-5-20210226","doi-asserted-by":"crossref","first-page":"443","DOI":"10.7326\/0003-4819-128-6-199803150-00004","article-title":"Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome. A randomized, double-blind, placebo-controlled trial.","volume":"128","author":"Hamuryudan","year":"1998","journal-title":"Ann Intern Med"},{"key":"R10-5-20210226","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/S0140-6736(84)91622-2","article-title":"Thalidomide in severe orogenital ulceration.","volume":"2","author":"Jenkins","year":"1984","journal-title":"Lancet"},{"key":"R11-5-20210226","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaad.2004.10.863","article-title":"Complex aphthosis: a large case series with evaluation algorithm and therapeutic ladder from topicals to thalidomide.","volume":"52","author":"Letsinger","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R12-5-20210226","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archderm.1994.01690010070009","article-title":"Thalidomide neuropathy incidence and clinicoelectrophysiologic findings in 42 patients.","volume":"130","author":"Ochonisky","year":"1994","journal-title":"Arch Dermatol"},{"key":"R13-5-20210226","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5070\/D35FK5W0QV","article-title":"A review of thalidomide's history and current dermatological applications.","volume":"9","author":"Perri","year":"2003","journal-title":"Dermatol Online J"},{"key":"R14-5-20210226","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archderm.1990.01670310085012","article-title":"Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis.","volume":"126","author":"Revuz","year":"1990","journal-title":"Arch Dermatol"},{"key":"R15-5-20210226","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S1085-5629(97)80017-X","article-title":"Recurrent aphthous stomatitis: clinical characteristics and associated systemic disorders.","volume":"16","author":"Rogers","year":"1997","journal-title":"Semin Cutan Med Surg"},{"key":"R16-5-20210226","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1056\/NEJMcp054630","article-title":"Aphthous ulceration.","volume":"355","author":"Scully","year":"2006","journal-title":"N Engl J Med"},{"key":"R17-5-20210226","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bjoms.2007.07.201","article-title":"Oral mucosal disease: recurrent aphthous stomatitis.","volume":"46","author":"Scully","year":"2008","journal-title":"Br J Oral Maxillofac Surg"},{"key":"R18-5-20210226","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/archderm.1982.01650230003002","article-title":"Thalidomide treatment of recurrent necrotic giant mucocutaneous aphthae and aphthosis letter.","volume":"118","author":"Torras","year":"1982","journal-title":"Arch Dermatol"},{"key":"R19-5-20210226","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000018123","article-title":"Comparative analysis of severe aphthosis and Behcet's disease: 104 cases.","volume":"198","author":"Verpilleux","year":"1999","journal-title":"Dermatology"},{"key":"R20-5-20210226","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0248-8663(99)80105-2","article-title":"Traitement de l'aphtose recurrente par thalidomide: etude pilote chez 17 patients.","volume":"20","author":"de Wazieres","year":"1999","journal-title":"Rev Med Interne"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0b013e3181dfca14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T17:31:43Z","timestamp":1740072703000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201005000-00005"}},"subtitle":["A Multicenter Cohort Analysis"],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0b013e3181dfca14","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}